%PDF-1.5
%
1 0 obj
<<
/Lang (en)
/MarkInfo <<
/Marked true
>>
/Metadata 2 0 R
/Outlines 3 0 R
/PageLayout /OneColumn
/PageMode /UseOutlines
/Pages 4 0 R
/StructTreeRoot 5 0 R
/Type /Catalog
/ViewerPreferences <<
/DisplayDocTitle true
>>
>>
endobj
6 0 obj
<<
/Author (Gemeinsamer Bundesausschuss/Federal Joint Committee \(g-ba.de\))
/Category ()
/Comments ()
/Company ()
/CreationDate (D:20210916130303+02'00')
/Creator <4163726F626174205044464D616B65722031352066FC7220576F7264>
/Keywords (Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V: Esketamine \(Depression, treatment-resistant, in combination with SSRI or SNRI\))
/ModDate (D:20210916160624+02'00')
/Producer (Adobe PDF Library 15.0)
/SourceModified (D:20210913145443)
/Subject (Pharmaceuticals Directive \(AM-RL\))
/Title (Resolution)
>>
endobj
2 0 obj
<<
/Length 4632
/Subtype /XML
/Type /Metadata
>>
stream
2021-09-16T16:06:24+02:00
2021-09-16T13:03:03+02:00
2021-09-16T16:06:24+02:00
Acrobat PDFMaker 15 für Word
uuid:9577a958-7579-49d7-92f4-b1ec5dbef2d7
uuid:d32057dd-2475-4073-930f-1bd3328d192a
1
application/pdf
Resolution
Pharmaceuticals Directive (AM-RL)
Gemeinsamer Bundesausschuss/Federal Joint Committee (g-ba.de)
Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V: Esketamine (Depression
treatment-resistant
in combination with SSRI or SNRI)
Adobe PDF Library 15.0
Annex XII - Benefit Assessment of Medicinal Products with New Active Ingredients according to Section 35a SGB V: Esketamine (Depression, treatment-resistant, in combination with SSRI or SNRI)
D:20210913145443
endstream
endobj
3 0 obj
<<
/Count 9
/First 7 0 R
/Last 8 0 R
/Type /Outlines
>>
endobj
4 0 obj
<<
/Count 7
/Kids [9 0 R 10 0 R 11 0 R 12 0 R 13 0 R 14 0 R 15 0 R]
/Type /Pages
>>
endobj
5 0 obj
<<
/K 16 0 R
/ParentTree 17 0 R
/ParentTreeNextKey 17
/RoleMap 18 0 R
/Type /StructTreeRoot
>>
endobj
7 0 obj
<<
/A 19 0 R
/Count 1
/First 20 0 R
/Last 20 0 R
/Next 8 0 R
/Parent 3 0 R
/Title (Resolution)
>>
endobj
8 0 obj
<<
/A 21 0 R
/Count 6
/First 22 0 R
/Last 23 0 R
/Parent 3 0 R
/Prev 7 0 R
/Title (I. Annex XII shall be amended in alphabetical order to include the active ingredient esketamine as follows:)
>>
endobj
9 0 obj
<<
/Contents [24 0 R 25 0 R 26 0 R 27 0 R 28 0 R 29 0 R 30 0 R 31 0 R 32 0 R 33 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 34 0 R]
/CS1 [/ICCBased 35 0 R]
>>
/Font <<
/TT0 36 0 R
/TT1 37 0 R
/TT2 38 0 R
>>
/XObject <<
/OL1 39 0 R
/OL2 40 0 R
>>
>>
/Rotate 0
/StructParents 0
/Tabs /S
/Type /Page
>>
endobj
10 0 obj
<<
/Annots [41 0 R 42 0 R 43 0 R]
/Contents [44 0 R 45 0 R 46 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 34 0 R]
>>
/Font <<
/TT0 36 0 R
/TT1 37 0 R
/TT2 38 0 R
/TT3 47 0 R
/TT4 48 0 R
>>
/XObject <<
/OL1 39 0 R
/OL2 40 0 R
>>
>>
/Rotate 0
/StructParents 1
/Tabs /S
/Type /Page
>>
endobj
11 0 obj
<<
/Annots [49 0 R 50 0 R]
/Contents [51 0 R 52 0 R 53 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 34 0 R]
/CS1 [/ICCBased 35 0 R]
>>
/Font <<
/C2_0 54 0 R
/C2_1 55 0 R
/TT0 36 0 R
/TT1 37 0 R
/TT2 38 0 R
>>
/XObject <<
/OL1 39 0 R
/OL2 40 0 R
>>
>>
/Rotate 0
/StructParents 4
/Tabs /S
/Type /Page
>>
endobj
12 0 obj
<<
/Annots [56 0 R]
/Contents [57 0 R 58 0 R 59 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 34 0 R]
>>
/Font <<
/TT0 36 0 R
/TT1 37 0 R
/TT2 38 0 R
>>
/XObject <<
/OL1 39 0 R
/OL2 40 0 R
>>
>>
/Rotate 0
/StructParents 7
/Tabs /S
/Type /Page
>>
endobj
13 0 obj
<<
/Annots [60 0 R 61 0 R]
/Contents [62 0 R 63 0 R 64 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 34 0 R]
>>
/Font <<
/TT0 36 0 R
>>
/XObject <<
/OL1 39 0 R
/OL2 40 0 R
>>
>>
/Rotate 0
/StructParents 8
/Tabs /S
/Type /Page
>>
endobj
14 0 obj
<<
/Contents [65 0 R 66 0 R 67 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 34 0 R]
>>
/Font <<
/TT0 36 0 R
>>
/XObject <<
/OL1 39 0 R
/OL2 40 0 R
>>
>>
/Rotate 0
/StructParents 9
/Tabs /S
/Type /Page
>>
endobj
15 0 obj
<<
/Annots [68 0 R 69 0 R]
/Contents [70 0 R 71 0 R 72 0 R]
/CropBox [0.0 0.0 595.32 841.92]
/MediaBox [0.0 0.0 595.32 841.92]
/Parent 4 0 R
/Resources <<
/ColorSpace <<
/CS0 [/ICCBased 34 0 R]
/CS1 [/ICCBased 35 0 R]
>>
/Font <<
/TT0 36 0 R
/TT1 37 0 R
>>
/XObject <<
/OL1 39 0 R
/OL2 40 0 R
>>
>>
/Rotate 0
/StructParents 10
/Tabs /S
/Type /Page
>>
endobj
16 0 obj
<<
/K [73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R 82 0 R
83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R 92 0 R
93 0 R 94 0 R 95 0 R 96 0 R 97 0 R 98 0 R 99 0 R 100 0 R 101 0 R 102 0 R
103 0 R 104 0 R 105 0 R 106 0 R 107 0 R 108 0 R 109 0 R 110 0 R 111 0 R 112 0 R
113 0 R 114 0 R 115 0 R 116 0 R 117 0 R 118 0 R 119 0 R 120 0 R 121 0 R 122 0 R
123 0 R 124 0 R 125 0 R 126 0 R 127 0 R 128 0 R 129 0 R 130 0 R 131 0 R 132 0 R
133 0 R 134 0 R 135 0 R 136 0 R 137 0 R 138 0 R 139 0 R 140 0 R 141 0 R 142 0 R
143 0 R 144 0 R 145 0 R]
/P 5 0 R
/S /Sect
>>
endobj
17 0 obj
<<
/Nums [0 [73 0 R 74 0 R 75 0 R 76 0 R 77 0 R 78 0 R 79 0 R 80 0 R 81 0 R]
1 [82 0 R 83 0 R 84 0 R 85 0 R 86 0 R 87 0 R 88 0 R 89 0 R 90 0 R 91 0 R
92 0 R 93 0 R null 95 0 R 96 0 R 97 0 R null null 146 0 R null
null null null null 147 0 R 148 0 R 147 0 R null null null
149 0 R null null null 150 0 R null null 100 0 R 101 0 R 102 0 R
103 0 R 104 0 R 105 0 R null 151 0 R null 152 0 R 153 0 R 146 0 R 154 0 R]
2 155 0 R 3 148 0 R 4 [106 0 R null 108 0 R 109 0 R 110 0 R null 156 0 R null 157 0 R null
null 158 0 R null 159 0 R null 160 0 R null null 161 0 R null
162 0 R null 163 0 R null 164 0 R null 165 0 R 166 0 R 167 0 R null
168 0 R null 169 0 R 170 0 R 171 0 R null 172 0 R null 173 0 R 174 0 R
175 0 R null 176 0 R null 177 0 R 178 0 R 179 0 R null 180 0 R null
181 0 R null 182 0 R null 183 0 R null 184 0 R null 185 0 R null
186 0 R null 187 0 R null 188 0 R 112 0 R 113 0 R null 115 0 R 116 0 R
117 0 R 118 0 R null null null 120 0 R 189 0 R 190 0 R 191 0 R 192 0 R]
5 193 0 R 6 193 0 R 7 [121 0 R 122 0 R 123 0 R 124 0 R 125 0 R 126 0 R 127 0 R 128 0 R 129 0 R 130 0 R
131 0 R null 194 0 R null 195 0 R null null 196 0 R null 197 0 R
null 198 0 R null 199 0 R null 200 0 R null 201 0 R null 202 0 R
null 203 0 R 204 0 R null 205 0 R null 206 0 R null 207 0 R null
208 0 R 209 0 R null 210 0 R null 211 0 R 212 0 R null 213 0 R null
214 0 R 215 0 R null 216 0 R null 217 0 R 218 0 R null 219 0 R null
220 0 R 221 0 R null 222 0 R null 223 0 R 224 0 R null 225 0 R null
226 0 R null 227 0 R null 228 0 R 202 0 R]
8 [null 229 0 R null 230 0 R null null 231 0 R null 232 0 R null
233 0 R null 234 0 R null 235 0 R 236 0 R null 237 0 R null 238 0 R
239 0 R null 240 0 R null 241 0 R 242 0 R null 243 0 R null 244 0 R
245 0 R null 246 0 R null 247 0 R null 248 0 R null 249 0 R null
250 0 R null 251 0 R null 252 0 R null 253 0 R 254 0 R null 255 0 R
null 256 0 R 257 0 R null 258 0 R null 259 0 R 260 0 R null 261 0 R
null 262 0 R null 263 0 R null 264 0 R null 265 0 R 266 0 R null
267 0 R null 268 0 R 269 0 R null 270 0 R null 271 0 R 272 0 R null
273 0 R null 274 0 R null 275 0 R null 276 0 R null 277 0 R 278 0 R
null 279 0 R null 280 0 R 281 0 R null 282 0 R null 283 0 R 284 0 R
null 285 0 R null 286 0 R null 287 0 R null 288 0 R null 289 0 R
290 0 R null 291 0 R null 292 0 R null 293 0 R null 294 0 R null
295 0 R null 296 0 R null 297 0 R 298 0 R null 299 0 R null 300 0 R
301 0 R null 302 0 R null 303 0 R 304 0 R null 305 0 R null 306 0 R
307 0 R null 308 0 R null 309 0 R 310 0 R null 311 0 R null 312 0 R
313 0 R null 314 0 R null 315 0 R 316 0 R null 317 0 R null 318 0 R
319 0 R null 320 0 R null 321 0 R null 322 0 R 256 0 R 323 0 R 289 0 R]
9 [null 324 0 R null 325 0 R null null 326 0 R null 327 0 R null
328 0 R null 329 0 R null 330 0 R null 331 0 R null 332 0 R 333 0 R
null 334 0 R null 335 0 R 336 0 R null 337 0 R null 338 0 R 339 0 R
null 340 0 R null 341 0 R 342 0 R null 343 0 R null 344 0 R 345 0 R
null 346 0 R null 347 0 R 348 0 R null 349 0 R null 350 0 R null
351 0 R null 352 0 R 353 0 R null 354 0 R null 355 0 R 356 0 R null
357 0 R null 358 0 R null 359 0 R null 360 0 R 361 0 R null 362 0 R
null 363 0 R 364 0 R null 365 0 R null 366 0 R 367 0 R null 368 0 R
null 369 0 R null 370 0 R null 371 0 R 372 0 R null 373 0 R null
374 0 R 375 0 R null 376 0 R null 377 0 R 378 0 R null 379 0 R null
380 0 R 381 0 R null 382 0 R null 383 0 R 384 0 R null 385 0 R null
386 0 R 387 0 R null 388 0 R null 389 0 R null 390 0 R null 391 0 R
null 392 0 R 393 0 R null 394 0 R null 395 0 R 396 0 R null 397 0 R
null 398 0 R 399 0 R null 400 0 R null 401 0 R 402 0 R 135 0 R 136 0 R
137 0 R]
10 [138 0 R 139 0 R 140 0 R 141 0 R null null 142 0 R 143 0 R 144 0 R 145 0 R
403 0 R 404 0 R]
11 405 0 R 12 405 0 R 13 153 0 R 14 228 0 R
15 322 0 R 16 323 0 R]
>>
endobj
18 0 obj
<<
/Annotation /Span
/Artifact /P
/Bibliography /BibEntry
/Chart /Figure
/Diagram /Figure
/DropCap /Figure
/Endnote /Note
/Footnote /Note
/Fu#C3#9Fnotenzeichen /Span
/GBA_Aufz#C3#A4hlung#201. /P
/GBA_Datum /P
/GBA_Standard /P
/GBA_Verfasser /P
/Hyperlink /Span
/InlineShape /Figure
/Outline /Span
/Standard /P
/Strikeout /Span
/Subscript /Span
/Superscript /Span
/TextBox /Art
/Titel /H1
/Underline /Span
/Untertitel /H2
/#C3#9Cberschrift#201 /H1
/#C3#9Cberschrift#203 /H3
/#C3#9Cberschrift#204 /H4
>>
endobj
19 0 obj
<<
/D [9 0 R /XYZ 69 743 0.0]
/S /GoTo
>>
endobj
20 0 obj
<<
/A 406 0 R
/Parent 7 0 R
/Title (of the Federal Joint Committee on an Amendment of the Pharmaceuticals Directive \(AM-RL\))
>>
endobj
21 0 obj
<<
/D [9 0 R /XYZ 69 458 0.0]
/S /GoTo
>>
endobj
22 0 obj
<<
/A 407 0 R
/Next 408 0 R
/Parent 8 0 R
/Title (1. Additional benefit of the medicinal product in relation to the appropriate comparator therapy)
>>
endobj
23 0 obj
<<
/A 409 0 R
/Parent 8 0 R
/Prev 410 0 R
/Title (1. The resolution will enter into force on the day of its publication on the internet on the website of the Federal Joint Committee on 19 August 2021.)
>>
endobj
24 0 obj
<<
/Length 37
/Filter /FlateDecode
>>
stream
x+*23P0bdBr.KB W
endstream
endobj
25 0 obj
<<
/Length 37
/Filter /FlateDecode
>>
stream
x+*23P0bdBr.KB W
endstream
endobj
26 0 obj
<<
/Length 777
/Filter /FlateDecode
>>
stream
HUN1Wt*oBr1PfHDJ>=3d@01,]s{v+:8VzqI6;>EIRrpC(+C~~_~Xb~xٹ;W7wtxx鄺gcWr4
=-NXʐc92=jʺ+/W0Hc
! އ^ ]^v}^zD.bl^#<1bKU/$X&$Hĉx+n>-
Fz@l5jR6 lj y^F$InƖ6O`6|lHaˬ]f}TY`
,![$=MP5H|i=GҪǢrUH΄-#=QYYBYm;J(T M3 #"6
67촂cSRް\a6CnZZZ٤4
< ҩ<ݗjI:[i+\H+*fUj~JiJH* dÆ.F} WKN'WS&hC)|j%vA
V7d"ۿ8-n_@B~͜J{\%)i9K%(sa*2iZ juRѲUUn+8}1?$~Ts鉙][>7ԋk#a_?Vؚ^̚^ַaݻG I
endstream
endobj
27 0 obj
<<
/Length 811
/Filter /FlateDecode
>>
stream
HUKnG)xQH9 zrTU?IƳ!Y.O|vFV+nz}o?y[k2瓻]/]ߡ?7 c|tYk